Uncategorized

The FDA convened a committee of advisers to assess a cardiac device made by Abbott, but the agency did not disclose that 10 of the 14 members had received payments from the company or conducted research it had funded, KFF…

By 2050, new cancer diagnoses are expected to reach 35 million worldwide — up from the 20 million cases diagnosed in 2022, according to the American Cancer Society's 2024 report on global cancer statistics. 

A recent study by researchers at Brigham and Women's Hospital and Harvard Medical School, both based in Boston, found only 43% of cancer drugs granted accelerated FDA approval demonstrated clinical benefit in confirmatory trials.

Los Angeles-based Keck Medicine of USC will assess the feasibility of providing home-based immunotherapy to patients with non-small cell lung cancer via a new clinical trial.

In the U.S., 1 in 5 people with cancer participate in some form of clinical research, according to the first report to estimate participation levels across all types of cancer studies. 

The FDA has approved an artificial intelligence algorithm for Eko Health's digital stethoscope that can detect low ejection fraction, a key indicator of heart failure.

The University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute has named Yong Zhu, PhD, associate director for population science and translational science, the Little Rock-based organization said April 2.

WVU Medicine is expanding its advanced cardiac services with the launch of an open-heart surgery program at its Thomas Hospitals in South Charleston, W. Va. 

Northwell Health has tapped Andrew Krumerman, MD, to be its director of cardiac electrophysiology for Mount Kisco, N.Y.-based Northern Westchester Hospital.

Here are 100 hospitals and health systems that opened cancer centers or expanded cancer care services in 2024: